Gensci-134 (Genescience Pharmaceuticals Co. Ltd.) is a growth hormone receptor (GHR) agonist fusion protein that mimics the biological activity of growth hormone (GH), does not contain GH sequence and ...

Genescience Pharma Private Limited is a Non-govt company, incorporated on 27 Dec, 2011. It's a private unlisted company and is classified as'company limited by shares'. Company's authorized capital ...

Ethyreal Bio has exited stealth with $101 million in funding, joining the queue of companies preparing to challenge Amgen’s Tepezza. Backed by series A and B round investors, including Atlas Venture ...

Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder characterized by dysregulation in humoral immunity and sustained activation of B cells and autoantibody release, where BAFF (B-cell ...

DelveInsight's “Endometriosis Pipeline Insight 2025” report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in Endometriosis pipeline landscape. It covers the Endometriosis ...

Endometriosis is a prevalent yet underdiagnosed disease affecting a large population of women of reproductive age, with a substantial and lasting impact on quality of life and fertility. While rising ...

Shanghai Scizeng Medical Technology Co Ltd - a subsidiary of Changchun GeneScience Pharmaceutical Co Ltd (GenSci), RTW Investments, a New York-based global full life-cycle investment firm and Yarrow ...

Shanghai Scizeng Medical Technology, a subsidiary of Changchun GeneScience Pharmaceutical (GenSci), RTW Investments and privately-held US biotech Yarrow Bioscience have announced an exclusive global ...

Yarrow Bioscience, financially backed by founder RTW Investments, will pay $70 million upfront for ex-China rights to a potentially first-in-class TSHR antibody drug. (Pro2sound/iStock/Getty Images ...

Collaboration to focus on building a leading, US-based biotech dedicated to addressing underserved patients impacted by autoimmune and endocrinology disorders GenSci to receive $70 million ...

Shanghai Scizeng Medical Technology Co., LTD, a subsidiary of Changchun GeneScience Pharmaceutical Co., Ltd. ("GenSci"), RTW Investments, LP ("RTW"), and Yarrow Bioscience, Inc. ("Yarrow") today ...

DelveInsight's 'Thyroid Eye Disease Pipeline Insight 2025' report provides comprehensive global coverage of pipeline thyroid eye disease therapies in various stages of clinical development, major ...